Raf -
I think it will jump around some with a generally upward trend until Nov 9, with the price around $25 at that time. On the afternoon of Nov. 10, I expect outstanding results to be announced, with a rise to low-mid $30's over the next few days. Once the article comes out (by end of year), I think it will go up more. My guess is near $40 by end of year. To go out on a limb, I think they start seeing BO offers before March, at minimum of $45-50/sh. No idea if they would take that.
If AHA results are not great (unlikely), I see price staying in mid-20's short term, increasing to 30s over next 6 months.